Amedeo Smart

Free Medical Literature Service




  Free Subscription


2 Acad Emerg Med
2 Am J Respir Crit Care Med
1 Antiviral Res
17 BMJ
1 Br J Anaesth
4 Clin Infect Dis
13 Emerg Infect Dis
1 Graefes Arch Clin Exp Ophthalmol
5 Infect Control Hosp Epidemiol
10 Int J Infect Dis
1 Intensive Care Med
9 J Infect
12 J Med Virol
1 J Virol
4 Lancet
3 Lancet Infect Dis
7 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
13 Nature
1 Pol J Radiol
1 Radiol Imaging Cancer
5 Science

    Acad Emerg Med

  1. ELBERTS SJ, Bateman R, Koutsoubis A, London KS, et al
    The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism.
    Acad Emerg Med. 2021 Aug 23. doi: 10.1111/acem.14348.
    >> Share

  2. LEE LK, Stewart A, Mannix R
    And So They Wait: The Other Epidemic Among United States Youth During COVID-19.
    Acad Emerg Med. 2021 Aug 26. doi: 10.1111/acem.14380.
    >> Share

    Am J Respir Crit Care Med

  3. GERARD L, Lecocq M, Bouzin C, Hoton D, et al
    Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19 Related ARDS.
    Am J Respir Crit Care Med. 2021 Aug 27. doi: 10.1164/rccm.202012-4461.
    >> Share

  4. KITSIOS GD, Morris A
    Seek and Ye Shall Find: COVID-19 and Bacterial Superinfection.
    Am J Respir Crit Care Med. 2021 Aug 25. doi: 10.1164/rccm.202107-1790.
    >> Share

    Antiviral Res

  5. GARCIA-DORIVAL I, Cuesta-Geijo MA, Barrado-Gil L, Galindo I, et al
    Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target.
    Antiviral Res. 2021 Aug 24:105167. doi: 10.1016/j.antiviral.2021.105167.
    >> Share


    Covid-19: FDA set to grant full approval to Pfizer vaccine without public discussion of data.
    BMJ. 2021;374:n2086.
    >> Share

    Why the Philippines' long lockdowns couldn't contain covid-19.
    BMJ. 2021;374:n2063.
    >> Share

  8. RANZANI OT, Hitchings MDT, Dorion M, D'Agostini TL, et al
    Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    BMJ. 2021;374:n2015.
    >> Share

    Covid-19: UK approves first monoclonal antibody treatment.
    BMJ. 2021;374:n2083.
    >> Share

  10. MAHASE E
    Covid-19 booster vaccines: What we know and who's doing what.
    BMJ. 2021;374:n2082.
    >> Share

  11. MARCHETTI F, Tamburlini G
    Other good reasons for covid-19 vaccination in pre-adolescent and adolescent populations.
    BMJ. 2021;374:n2052.
    >> Share

  12. CHUNG H, He S, Nasreen S, Sundaram ME, et al
    Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    BMJ. 2021;374:n1943.
    >> Share

  13. TANNE JH
    Covid-19: US hospitals are overwhelmed as cases rise at "alarming rate".
    BMJ. 2021;374:n2092.
    >> Share

  14. MAHASE E
    Covid-19 vaccines: GPs boost uptake by calling patients and teaming up with community groups.
    BMJ. 2021;374:n2093.
    >> Share

  15. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    >> Share

    Covid-19: UK cases continue to rise amid warnings of impact of schools reopening.
    BMJ. 2021;374:n2124.
    >> Share

    Covid-19: Protection from two doses of vaccine wanes within six months, data suggest.
    BMJ. 2021;374:n2113.
    >> Share

  18. MUNRO C
    Covid-19: 40% of patients with weakened immune system mount lower response to vaccines.
    BMJ. 2021;374:n2098.
    >> Share

  19. RIDER EA, Ansari E, Varrin PH, Sparrow J, et al
    Mental health and wellbeing of children and adolescents during the covid-19 pandemic.
    BMJ. 2021;374:n1730.
    >> Share

    Polarisation, incivility, and scientific debate during covid-19-an essay by Agnes Arnold-Forster.
    BMJ. 2021;374:n1888.
    >> Share

    Covid-19: Which countries are doing well on test and trace-and how can we tell?
    BMJ. 2021;374:n2053.
    >> Share

  22. TANNE JH
    Covid-19: FDA approves Pfizer-BioNTech vaccine in record time.
    BMJ. 2021;374:n2096.
    >> Share

    Br J Anaesth

  23. SANFILIPPO F, Drago V, Bonelli G, Tigano S, et al
    COVID-19: a boost for intensive care authorship?
    Br J Anaesth. 2021 Jul 29. pii: S0007-0912(21)00463.
    >> Share

    Clin Infect Dis

  24. PETTI S
    Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019.
    Clin Infect Dis. 2021 Aug 22. pii: 6356216. doi: 10.1093.
    >> Share

  25. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
    Clin Infect Dis. 2021 Aug 22. pii: 6356217. doi: 10.1093.
    >> Share

  26. NARAYANAN S, Chua JV, Baddley JW
    COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease.
    Clin Infect Dis. 2021 Aug 22. pii: 6356215. doi: 10.1093.
    >> Share

  27. ONG SWX, Chiew CJ, Ang LW, Mak TM, et al
    Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).
    Clin Infect Dis. 2021 Aug 23. pii: 6356459. doi: 10.1093.
    >> Share

    Emerg Infect Dis

  28. MURPHY M, Dhrolia I, Zanowick-Marr A, Tao J, et al
    A Community-Adapted Approach to SARS-CoV-2 Testing for Medically Underserved Populations, Rhode Island, USA.
    Emerg Infect Dis. 2021;27:2445-2449.
    >> Share

  29. LI Y, Liu J, Yang Z, Yu J, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 to Close Contacts, China, January-February 2020.
    Emerg Infect Dis. 2021;27:2288-2293.
    >> Share

  30. REGO N, Costabile A, Paz M, Salazar C, et al
    Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.
    Emerg Infect Dis. 2021;27.
    >> Share

  31. HOLLOWAY P, Gibson M, van Doremalen N, Nash S, et al
    Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014-2018.
    Emerg Infect Dis. 2021;27:2301-2311.
    >> Share

  32. CANTO E CASTRO L, Pereira AHG, Ribeiro R, Alves C, et al
    Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal.
    Emerg Infect Dis. 2021;27.
    >> Share

  33. PETERSEN MS, Kristiansen MF, Reinert HW, Fjallsbak JP, et al
    Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020.
    Emerg Infect Dis. 2021;27.
    >> Share

  34. KIM HY, Oh IH, Lee J, Seon JY, et al
    Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden, South Korea.
    Emerg Infect Dis. 2021;27.
    >> Share

  35. IMMERGLUCK K, Gonzalez MD, Frediani JK, Levy JM, et al
    Correlation of SARS-CoV-2 Subgenomic RNA with Antigen Detection in Nasal Midturbinate Swab Specimens.
    Emerg Infect Dis. 2021;27.
    >> Share

  36. MAEDA H, Sando E, Toizumi M, Arima Y, et al
    Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020.
    Emerg Infect Dis. 2021;27:2251-2260.
    >> Share

  37. DOUGLAS J, Geoghegan JL, Hadfield J, Bouckaert R, et al
    Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand.
    Emerg Infect Dis. 2021;27:2361-2368.
    >> Share

  38. MCCLARY-GUTIERREZ JS, Mattioli MC, Marcenac P, Silverman AI, et al
    SARS-CoV-2 Wastewater Surveillance for Public Health Action.
    Emerg Infect Dis. 2021;27:1-8.
    >> Share

  39. RACNIK J, Kocevar A, Slavec B, Korva M, et al
    Transmission of SARS-CoV-2 from Human to Domestic Ferret.
    Emerg Infect Dis. 2021;27:2450-2453.
    >> Share

  40. RABALSKI L, Kosinski M, Smura T, Aaltonen K, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 in Farmed Mink (Neovison vison), Poland.
    Emerg Infect Dis. 2021;27:2333-2339.
    >> Share

    Graefes Arch Clin Exp Ophthalmol

  41. CACCIAMANI A, Scarinci F, Bruno L, Balzamino BO, et al
    Phacoemulsification and nucleic acid-enriched aerosol: considerations from an eye model of cataract simulation.
    Graefes Arch Clin Exp Ophthalmol. 2021 Aug 26. pii: 10.1007/s00417-021-05350.
    >> Share

    Infect Control Hosp Epidemiol

  42. VOLPATO FCZ, Wink PL, Monteiro FL, Willig JB, et al
    Early detection of the SARS-CoV-2 P.1 variant in Rio Grande do Sul, Brazil: a case report.
    Infect Control Hosp Epidemiol. 2021 Aug 27:1-7. doi: 10.1017/ice.2021.
    >> Share

  43. BABADY NE, Cohen B, McClure T, Chow K, et al
    Variable Duration of Viral Shedding in Cancer Patients with COVID-19.
    Infect Control Hosp Epidemiol. 2021 Aug 27:1-15. doi: 10.1017/ice.2021.
    >> Share

  44. SMITH L, Pau S, Fallon S, Cosgrove SE, et al
    Impact of Weekly Asymptomatic Testing for SARS-CoV-2 Virus in Inpatients at an Academic Hospital.
    Infect Control Hosp Epidemiol. 2021 Aug 27:1-8. doi: 10.1017/ice.2021.
    >> Share

  45. BEAM EL
    Respiratory protection for health professions students must be addressed in light of lessons from the coronavirus disease 2019 (COVID-19) pandemic.
    Infect Control Hosp Epidemiol. 2021 Aug 20:1-2. doi: 10.1017/ice.2021.
    >> Share

  46. JAMAL SA, Rayapati A
    A look into the relationship between outdated Covid-19 treatment protocols and the overwhelming rise of Mucormycosis in Covid-19 patients in India.
    Infect Control Hosp Epidemiol. 2021 Aug 27:1-5. doi: 10.1017/ice.2021.
    >> Share

    Int J Infect Dis

  47. L SBB, Wanve S, Koradia P, Bhomia V, et al
    Efficacy and Safety of Pegylated Interferon-alpha2b in Moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00677.
    >> Share

  48. MOUALLEM RE, Moussally K, Williams A, Repetto E, et al
    How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle-East.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00668.
    >> Share

  49. VAN HEERDEN J, Nel J, Moodley P, Govender P, et al
    Multisystem Inflammatory Syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00673.
    >> Share

  50. YANG J, Han Y, Zhang R, Zhang R, et al
    Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00676.
    >> Share

  51. VAN DAM CS, Lede I, Schaar J, Al-Dulaimy M, et al
    Herpes Zoster after COVID-vaccination.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00681.
    >> Share

  52. BHANUPRASAD K, Manesh A, Devasagayam E, Varghese L, et al
    Risk Factors Associated with the Mucormycosis Epidemic During the COVID-19 Pandemic.
    Int J Infect Dis. 2021 Aug 24. pii: S1201-9712(21)00670.
    >> Share

  53. TIMELLI L, Liuzzi G, Cannavacciuolo A, Petrosillo N, et al
    Association of COVID-19 case-fatality rate with disease burden: an ecological analysis in Italy during the first wave.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00665.
    >> Share

  54. GONG C, Song X, Li X, Lu L, et al
    Immunological Changes after COVID-19 Vaccination in an HIV-Positive Patient.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00667.
    >> Share

  55. VELAVAN T, Pallerla S, Kremsner P
    How to ab(use) a COVID-19 antigen rapid test with soft drinks?
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00654.
    >> Share

  56. CUI LY, Cheng WW, Mou ZW, Xiao D, et al
    Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis.
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00649.
    >> Share

    Intensive Care Med

  57. DE METZ J, Thoral PJ, Chorus CG, Elbers PWG, et al
    Behavioural artificial intelligence technology for COVID-19 intensivist triage decisions: making the implicit explicit.
    Intensive Care Med. 2021 Aug 25. pii: 10.1007/s00134-021-06453.
    >> Share

    J Infect

  58. WANG C, Kang K, Lan X, Fei D, et al
    Cytokinelevels in sputum, not serum, may be more helpful 1 for indicating the damage in the lung and the prognosis of severe COVID-19 - A Case Series.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00415.
    >> Share

  59. QIU S, Hu Y
    Are COVID-19 susceptibility genes related to lung cancer?
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00434.
    >> Share

  60. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
    >> Share

  61. GUIGON A, Faure E, Lemaire C, Chopin MC, et al
    Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00435.
    >> Share

  62. MORALES-ORTEGA A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al
    Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00436.
    >> Share

  63. TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
    The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
    >> Share

  64. BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
    Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
    >> Share

  65. KRAL S, Banfi C, Niedrist T, Sareban N, et al
    Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
    J Infect. 2021 Aug 22. pii: S0163-4453(21)00419.
    >> Share

  66. YOU YS, Kim JS
    Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
    J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
    >> Share

    J Med Virol

  67. ZAWBAA HM, Osama H, El-Gendy A, Saeed H, et al
    Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27293.
    >> Share

  68. MURAT K, Ediz TE
    The Effectiveness of Inactivated SARS-CoV-2 Vaccine (CoronaVac) on Antibody Response in Participants Aged 65 Years and Older.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27289.
    >> Share

  69. YAZDANPANAH N, Rezaei N
    Autoimmune Complications of COVID-19.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27292.
    >> Share

  70. STRUCK F, Schreiner P, Staschik E, Wochinz-Richter K, et al
    Incomplete IgG avidity maturation after seasonal coronavirus infections.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27291.
    >> Share

  71. BAYRAKTAR N, Turan H, Bayraktar M, Ozturk A, et al
    Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27294.
    >> Share

  72. CATALAN IP, Marti CR, Sota DP, Alvarez AC, et al
    "Corticosteroids for COVID-19 symptoms and quality of life at one year from admission".
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27296.
    >> Share

  73. PORTILHO AI, Silva VO, Ahagon CM, Matsuda EM, et al
    Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27290.
    >> Share

  74. CABRELLE G, Zanon C, Crimi F, Quaia E, et al
    Can rapid antibody tests and chest computed tomography really substitute real-time polymerase chain reaction in COVID-19?
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27295.
    >> Share

  75. SARKAR S, Kannan S, Khanna P, Singh AK, et al
    Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27297.
    >> Share

  76. PLASENCIA-DUENAS R, Failoc-Rojas VE, Rodriguez-Morales AJ
    Impact of the COVID-19 pandemic on the incidence of dengue fever in Peru.
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27298.
    >> Share

  77. OLEA B, Albert E, Torres I, Gozalbo-Rovira R, et al
    SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: frequency and association with inflammatory and tissue-damage biomarkers.
    J Med Virol. 2021 Aug 27. doi: 10.1002/jmv.27300.
    >> Share

  78. RATHORE SS, Hussain N, Manju AH, Wen Q, et al
    Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2021 Aug 27. doi: 10.1002/jmv.27301.
    >> Share

    J Virol

  79. LI X, Wang L, Liu P, Li H, et al
    A novel potentially recombinant rodent coronavirus with a polybasic cleavage site in the spike protein.
    J Virol. 2021 Aug 25:JVI0117321. doi: 10.1128/JVI.01173.
    >> Share


  80. WOOLFORD SJ, Sidell M, Li X, Else V, et al
    Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic.
    JAMA. 2021 Aug 27. pii: 2783690. doi: 10.1001/jama.2021.15036.
    >> Share

  81. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    >> Share

  82. KUEHN BM
    Post-COVID-19 Symptoms Were Worse Than Cancer's Effects.
    JAMA. 2021;326:692.
    >> Share

  83. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
    >> Share


  84. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    >> Share

  85. SHROTRI M, Navaratnam AMD, Nguyen V, Byrne T, et al
    Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
    Lancet. 2021;398:385-387.
    >> Share

  86. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    >> Share

  87. CONLY J, Chou R, Schwaber MJ, Voss A, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660.
    >> Share

    Lancet Infect Dis

  88. BEAUTE J, Adlhoch C, Bundle N, Melidou A, et al
    Testing indicators to monitor the COVID-19 pandemic.
    Lancet Infect Dis. 2021 Aug 24. pii: S1473-3099(21)00461.
    >> Share

  89. TEMPE DK
    Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
    Lancet Infect Dis. 2021 Aug 24. pii: S1473-3099(21)00450.
    >> Share

  90. UDWADIA Z, Balsari S, Ghafur A
    Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? - Authors' reply.
    Lancet Infect Dis. 2021 Aug 24. pii: S1473-3099(21)00480.
    >> Share

    MMWR Morb Mortal Wkly Rep

  91. BIGOUETTE JP, Wilkinson AL, Tallis G, Burns CC, et al
    Progress Toward Polio Eradication - Worldwide, January 2019-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1129-1135.
    >> Share

  92. ROSENBERG ES, Holtgrave DR, Dorabawila V, Conroy M, et al
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1150-1155.
    >> Share

  93. GRIFFIN JB, Haddix M, Danza P, Fisher R, et al
    SARS-CoV-2 Infections and Hospitalizations Among Persons Aged >/=16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1170-1176.
    >> Share

  94. TENFORDE MW, Self WH, Naioti EA, Ginde AA, et al
    Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1156-1162.
    >> Share

  95. FOWLKES A, Gaglani M, Groover K, Thiese MS, et al
    Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1167-1169.
    >> Share

  96. NANDURI S, Pilishvili T, Derado G, Soe MM, et al
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-Au
    MMWR Morb Mortal Wkly Rep. 2021;70:1163-1166.
    >> Share

  97. CZEISLER ME, Board A, Thierry JM, Czeisler CA, et al
    Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic - United States, February-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1142-1149.
    >> Share

    N Engl J Med

    When Low Tech Wins.
    N Engl J Med. 2021;385:581-583.
    >> Share

  99. PHILLIPS S, Williams MA
    Confronting Our Next National Health Disaster - Long-Haul Covid.
    N Engl J Med. 2021;385:577-579.
    >> Share

  100. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Booster Shots.
    N Engl J Med. 2021;385:e29.
    >> Share

  101. BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
    >> Share

  102. UZUN G, Althaus K, Bakchoul T
    No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
    >> Share

  103. LEE GM
    The Importance of Context in Covid-19 Vaccine Safety.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
    >> Share


  104. ANNAVAJHALA MK, Mohri H, Wang P, Nair M, et al
    Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.
    Nature. 2021 Aug 24. pii: 10.1038/s41586-021-03908.
    >> Share

    How Nature's COVID coverage has made a difference.
    Nature. 2021 Aug 24. pii: 10.1038/d41586-021-02277.
    >> Share

    How Zoom helped the neurotypical world hear my autistic voice.
    Nature. 2021 Aug 25. pii: 10.1038/d41586-021-02325.
    >> Share

  107. TAYLOR L
    The Venezuelan health-care workers secretly collecting COVID stats.
    Nature. 2021 Aug 25. pii: 10.1038/d41586-021-02276.
    >> Share

  108. KOOPMANS M, Daszak P, Dedkov VG, Dwyer DE, et al
    Origins of SARS-CoV-2: window is closing for key scientific studies.
    Nature. 2021;596:482-485.
    >> Share

  109. PEI S, Yamana TK, Kandula S, Galanti M, et al
    Burden and characteristics of COVID-19 in the United States during 2020.
    Nature. 2021 Aug 26. pii: 10.1038/s41586-021-03914.
    >> Share

  110. BANDARA N
    Five hundred days between pay cheques: the road I took to revive my career.
    Nature. 2021 Aug 26. pii: 10.1038/d41586-021-02359.
    >> Share

  111. LEDFORD H
    COVID vaccines and blood clots: what researchers know so far.
    Nature. 2021;596:479-481.
    >> Share

  112. KATHPALIA P, Konar A, Pillai B
    Home laboratory: interactive science from the kitchen.
    Nature. 2021;596:486.
    >> Share

    The mutation that helps Delta spread like wildfire.
    Nature. 2021;596:472-473.
    >> Share

  114. GILBERT N
    UK academics seethe over universities' cost-cutting moves.
    Nature. 2021;596:307-308.
    >> Share

  115. BUCKLEY R, Brough P
    Mental health: set up long-term cohort studies.
    Nature. 2021;595:352.
    >> Share

  116. PADMA TV
    COVID vaccines to reach poorest countries in 2023 - despite recent pledges.
    Nature. 2021;595:342-343.
    >> Share

    Pol J Radiol

  117. ABO-HEDIBAH SA, Tharwat N, Elmokadem AH
    Is chest X-ray severity scoring for COVID-19 pneumonia reliable?
    Pol J Radiol. 2021;86:e432-e439.
    >> Share

    Radiol Imaging Cancer

  118. LUKER GD
    Celebrating Our First Year Together at Radiology: Imaging Cancer.
    Radiol Imaging Cancer. 2020;2:e209029.
    >> Share


    Do chronic infections breed dangerous new variants?
    Science. 2021;373:848.
    >> Share

    Will COVID-19 change science? Past pandemics offer clues.
    Science. 2021;373:264-265.
    >> Share

  121. WANG CC, Prather KA, Sznitman J, Jimenez JL, et al
    Airborne transmission of respiratory viruses.
    Science. 2021;373.
    >> Share

  122. WADMAN M
    Israel's grim warning: Delta can overwhelm shots.
    Science. 2021;373:838-839.
    >> Share

    Evolving threat.
    Science. 2021;373:844-849.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016